Bijl, Marc

Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab

van Assen, S., Holvast, A., Benne, C. A., Posthumus, M. D., van Leeuwen, M. A., Voskuyl, A. E., Blom, M., Risselada, A. P., de Haan, A., Westra, J., et al. (2010) · Arthritis & Rheumatism

Rheumatoid Arthritis Research and TherapiesInfluenza Virus Research Studies

Cited by 371

Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations

Rondaan, C., Furer, V., Heijstek, M. W., Agmon-Levin, N., Bijl, M., Breedveld, F. C., D’Amelio, R., Dougados, M., Kapetanovic, M. C., van Laar, J. M., et al. (2019) · RMD Open

Rheumatoid Arthritis Research and TherapiesVaccine Coverage and Hesitancy

Cited by 154

Rituximab impairs immunoglobulin (Ig)M and IgG (subclass) responses after influenza vaccination in rheumatoid arthritis patients

Westra, J., van Assen, S., Wilting, K. R., Land, J., Horst, G., de Haan, A., & Bijl, M. (2014) · Clinical and Experimental Immunology

Rheumatoid Arthritis Research and TherapiesInfluenza Virus Research Studies

Cited by 92